Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Patient Educ Couns. 2017 Mar 22;100(8):1527–1536. doi: 10.1016/j.pec.2017.03.024

Table 2.

Patient advocate and oncology practitioner cohorts participating in acceptability testing

Sample Characteristic Patient Advocate Cohort
n (%); N=57
Practitioner Cohort
n (%); N=25
Advocacy Perspective
 Cancer patient/survivor 26 (46)
 Caregiver 7 (12)
 Both patient and caregiver 7 (12)
 Neither patient nor caregiver 16 (28)
Colorectal cancer primary focus of advocacy work
 Yes 12 (21)
 No 45 (79)
Prior chemotherapy receipt (advocate, or patient for whom the advocate served as caregiver)
 Yes 35 (61)
Advanced cancer diagnosis (advocate, or patient for whom the advocate served as caregiver)
 Yes 28 (49)
Professional Role
 Medical oncologist 22 (88)
 Medical oncology mid-level provider 3 (12)
Practice Site
 Academic medical center 22 (88)
 Community practice 3 (12)
Gender
 Male 6 (11) 14 (56)
 Female 34 (60) 11 (44)
Age
 ≤39 7 (12) 14 (56)
 40–49 7 (12) 4 (16)
 50–59 13 (26) 6 (24)
 60–69 9 (16) 1 (4)
 ≥70 4 (7) 0
Race/Ethnicity
 White 35 (61) 21 (84)
 Black 6 (11) 1 (4)
 Asian/other 1 (2) 3 (12)
 Hispanic 2 (4) 1 (4)
Education
 High school or some college 2 (4)
 College graduate 18 (32)
 Graduate or professional degree 22 (39)

Colum percentages may not add to 100% due to missing data